Larkin Finbar 4
4 · Jazz Pharmaceuticals plc · Filed Sep 10, 2020
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Sale
Ordinary Shares
2020-09-09$138.53/sh−63$8,727→ 14,161 total
Footnotes (2)
- [F1]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Includes 106 and 132 ordinary shares purchased on March 15, 2019 and March 13, 2020 respectively by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme in transactions exempt under Rule 16b-3(c). Also includes 103 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2020.